+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Flavonoids in Dietary Supplements Market: By form; By Flavonoid Class; By Application & By Geography - Forecast 2017-2022

  • Report

  • 159 Pages
  • March 2018
  • Region: Global
  • IndustryARC
  • ID: 4532576
Flavonoids are generally produces from collection of phytonutrients along with antioxidant properties. These are mainly visible in plants and are responsible for the colour of any vegetable, fruit, grain, or flower considering carrots, tea, citrus fruits, berries, broccoli, peppers, squash, tomatoes, eggplant, and soybean. Whereas coming to Dietary Supplements are also occurs from plants itself, animal organs, microbial strains, and seafood, that are useful for improving the intake of required nutrients in the human body. The net market of the flavonoids in dietary supplements estimated to $XX billion in 2017 and forecasts to $XX billion in 2023 with a CAGR of $XX% between 2017 and 2023.

Growing innovations of new forms in “flavonoids” is increasing the demand for flavonoids in dietary supplements globally. The raising in the demand for interests in calorie reduction and loss weight is one of the ley factors driving the market of flavonoids in dietary supplements. Flavonoids in Dietary Supplements can be categorized into forms, flavonoid glass, application and geography.

The market for “Flavonoids in Dietary Supplements” is segmented on regions into North America, Europe, APAC, and Rest of the World. Competitive landscape for industry and market players are profiled with attributes of company overview, business strategy, and product portfolio.

Sample Companies profiled in the report are:

Extrasynthese
Kemin Industries, Inc.

Quercegen Pharmaceuticals
10+
These companies hold substantial share owing to the fragmented and grey nature of the industry and rest of the market players are original chunks to regional and other local level manufacturers. Other players have considerable share owing to its robust image, geographical reach, and strong customer base.

Table of Contents

1. Flavonoids in Dietary Supplements Market Overview2. Flavonoids in Dietary Supplements Market- Executive Summary
3. Flavonoids in Dietary Supplements Market Landscape
3.1. Market Share Analysis
3.2. Competitive analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent analysis
3.2.4. Top 5 Financials Analysis
4. Flavonoids in Dietary Supplements Market Forces
4.1. Market Drivers
4.2. Market Constraints/Challenges
4.3. Porter’s Five Forces
4.3.1. Power of Suppliers
4.3.2. Power of Buyers
4.3.3. Threat of New entrants
4.3.4. Threat of Substitution
4.3.5. Degree of Competition
5. Flavonoids in Dietary Supplements Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product/Market Life Cycle Analysis
6. Flavonoids in Dietary Supplements Market - By Form
6.1. Introduction
6.2. Tablets
6.3. Soft Gels
6.4. Capsules
6.5. Pills
6.6. Powder
6.7. Liquid
7. Flavonoids in Dietary Supplements Market - By Flavonoid Class
7.1. Introduction
7.2. Curcumin
7.3. Quercetin
7.4. Resveratrol
8. Flavonoids in Dietary Supplements Market - By Application
8.1. Introduction
8.2. Sports Nutrition Supplements
8.3. Medicinal Supplement
8.4. Others (Weight loss and maintenance)
9. Flavonoids in Dietary Supplements Market - By Geography
9.1. Introduction
9.2. Global
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Spain
9.3.6. The Netherlands
9.3.7. Rest of Europe
10. Flavonoids in Dietary Supplements Market Entropy
11. Flavonoids in Dietary Supplements Market - Company Profiles
11.1. Extrasynthese(France)
11.2. Kemin Industries, Inc (U.S.)
11.3. Quercegen Pharmaceuticals (U.S.)
11.4. RevGenetics (U.S.)
11.5. Monteloeder (Spain)
11.6. Kingherbs Limited (China)
11.7. Biomax Life Sciences Ltd. (India)
11.8. Hill Pharmaceutical Co., Ltd. (China)
11.9. GlaxoSmithKline plc. (U.K.)
11.10. Xieli Pharmaceuticals (China)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer

Methodology

Loading
LOADING...